Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB01319_nanopub.RArOXQmusEb4ctinespa4K2mXCejPo7t44YbCflV-A_58#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB01319 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB01319 label "DDI between Trazodone and Fosamprenavir - The protease inhibitor, Fosamprenavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Fosamprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB01319]" assertion.
- drugbank_resource:DB00656_DB01319 identifier "drugbank_resource:DB00656_DB01319" assertion.
- drugbank_resource:DB00656_DB01319 title "DDI between Trazodone and Fosamprenavir - The protease inhibitor, Fosamprenavir, may increase the efficacy/toxicity of Trazodone by inhibiting Trazodone metabolism and clearance. Monitor for changes in Trazodone efficacy/toxicity if Fosamprenavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB01319 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01319 assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB01319 assertion.